BRITTANY GAMBERI: Open Payments
NPI 1285332064 · NATCHEZ, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 46 payments from 12 companies in 2025. Trend: 2023 $414 · 2024 $913 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $375 |
| Ardelyx, Inc. | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Exact Sciences Corporation | 2 | $55 |
| Astellas Pharma US Inc | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
Products named: QULIPTA, CREON, IBSRELA, LINZESS, JARDIANCE, The Cologuard Plus Collection Kit, Veozah, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
